Tackling the Disproportionate Burden of Resistant Hypertension in US Black Adults
- PMID: 39235728
- PMCID: PMC11538188
- DOI: 10.1007/s11886-024-02115-5
Tackling the Disproportionate Burden of Resistant Hypertension in US Black Adults
Abstract
Purpose of review: Elevated blood pressure is the leading modifiable risk factor for cardiovascular morbidity and mortality in the US. Older individuals, Black adults, and those with comorbidities such as chronic kidney disease, have higher levels of uncontrolled and resistant hypertension. This review focuses on resistant hypertension, specifically in the US Black population, including potential benefits and limitations of current and investigational agents to address the disparate toll.
Recent findings: There is a necessity to implement public health measures, including early screening, detection, and evidence-based hypertension treatment with lifestyle, approved and investigational agents. The evidence highlights the importance of implementing feasible and cost-effective public health measures to advocate for early screening, detection, and appropriate treatment of hypertension. A team-based approach involving physicians, advanced practice nurses, physician assistants, pharmacists, social workers, and clinic staff to implement proven approaches and the delivery of care within trusted community settings may mitigate existing disparities.
Keywords: Black patients; Disparities; Implementation; Resistant hypertension.
© 2024. The Author(s).
Conflict of interest statement
Keith C. Ferdinand - Consultant for Amgen, Novartis, Janssen, Medtronic, Boehringer Ingelheim, Lilly.
All other authors declare no competing interests.
The authors declare no competing interests.
Figures
References
-
- Charchar FJ, Prestes PR, Mills C, Ching SM, Neupane D, Marques FZ, et al. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. J Hypertens. 2024;42(1):23–49. 10.1097/HJH.0000000000003563. - PMC - PubMed
-
- Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361–71. 10.1016/j.jacc.2022.11.005. - PubMed
-
- Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et a. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. 2024 Heart Disease and Stroke Statistics: A report of US and global data from the American Heart Association. Circulation. 2024;149(8):e347-e913. - PubMed
-
- Kazi DS, Elkind MSV, Deutsch A, Dowd WN, Heidenreich P, Khavjou O, et al. Forecasting the economic burden of cardiovascular disease and stroke in the United States through 2050: a presidential advisory from the American Heart Association. Circulation. 2024. 10.1161/CIR.0000000000001258. - PubMed
-
- Centers for Disease Control and Prevention and National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES) public use data files. https://cdc.gov/nchs/nhanes/ Accessed May 23, 2024.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
